Immune stimulation a class effect of phosphorothioate oligodeoxynucleotides in rodents

Anti-Cancer Drug Design

Volumn 12, Issue 5, 1997, Pages 421-432

  Monteith, David K ^a   Henry, Scott P ^a   Howard, Randy B ^a   Flournoy, Shin ^a   Levin, Arthur A ^a   Bennett, C Frank ^a   Crooke, Stanley T ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; ANTISENSE OLIGODEOXYNUCLEOTIDE; CGP 69846A; FOMIVIRSEN; ISIS 1082; ISIS 11061; ISIS 12449; ISIS 12959; ISIS 3082; ISIS 3521; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG STRUCTURE; HYPERGAMMAGLOBULINEMIA; IMMUNOSTIMULATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE PROLIFERATION; LYMPHOID HYPERPLASIA; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPLENOMEGALY; STRUCTURE ACTIVITY RELATION; SUBCUTANEOUS DRUG ADMINISTRATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; HUMANS; LYMPHOCYTE ACTIVATION; MACACA FASCICULARIS; MALE; MICE; MICE, NUDE; OLIGONUCLEOTIDES; SPLENOMEGALY; STIMULATION, CHEMICAL; STRUCTURE-ACTIVITY RELATIONSHIP; THIONUCLEOTIDES;

ANIMALIA; RODENTIA;

EID: 0030842828     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. BRANDA, R.F., MOORE, A.L., MATHEWS, L , MCCORMACK, J J. & ZON, G. (1993). Immune stimulation by an antisense oligomer complementary to the rev gene of HIV-1. Biochemical Pharmacology, 45, 2037.
2. 14C-labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats. Journal of Pharmacology and Experimental Therapeutics, 267, 1181.
3. 14C-labeled phosphorothioate oligonucleotide, ISIS 2105, after intradermal administration to rats. Journal of Pharmacology and Experimental Therapeutics, 269, 89.
4. CROOKE, R.M., GRAHAM, M.J., COOKE, M.E. & CROOKE, S.T. (1995). In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides. Journal of Pharmacology and Experimental Therapeutics, 275, 462.
5. 14C-labeled afovirsen sodium in patients with genital warts. Clinical and Pharmaceutical Therapeutics, 56, 641.
6. CROOKE, S.T , GRAHAM, M.J., ZUCKERMAN, J.E., BROOKS, D., CONKLIN, B.S., CUMMINS, L L., GREIG, M.J , GUINOSSO, C J., KORNBRUST, D., MANOHARAN, M. SASMOR, H.M , SCHLEICH, T , TIVEL, K.L. & GRIFFEY, R H (1996). Pharmacokinetic properties of several novel oligonucleotide analogs in mice. Journal of Pharmacology and Experimental Therapeutics, 277, 923.
7. DIAMANTSTEIN, T, WAGNER, B., BEYSE, I. ODENWALD, M.V. & SCHULTZ, G (1971). Stimulation of humoral antibody formation by polyanions. II The influence of sulfate esters of polymers on the immune response in mice. European Journal of Immunology, 1, 340.
8. HENRY, S.P., ORR, J.L., BRUNNER, R.H. & KORNBRUST, D.J. (1995). Effect of ISIS 1082, a phosphorothioate oligonucleotide, following subacute intradermal administration in Sprague-Dawley rats. Toxicology, in press.
9. HENRY, S.P., LEEDS, J., GICLAS, P.C , GILLETT, N.A., PRIBBLE, J.P., KORNBRUST, D.J. & LEVIN, A A. (1996). The toxicity of ISIS 3521, a phosphorothioate oligonucleotide, following intravenous (iv) and subcutaneous (sc) administration in cynomolgus monkeys. The Toxicologist, 30, 112.
10. HOKE, G. D., DRAPER, K., FREIER, S.M., GONZALEZ, C., DRIVER, V.B., ZOUNES, M.C. & ECKER, D J (1991). Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection. Nucleic Acids Research, 19, 5743.
11. HOMAN, E.R., ZENDZIAN, R.P., SCHOTT, L.D., LEVY, H. B. & ADAMSON, R H. (1972). Studies on poly I: C toxicity in experimental animals. Toxicology and Applied Pharmacology, 23, 579.
12. KLINMAN, D.M., AE-KYUNG, Y., BEAUCAGE, S.L., CONOVER, J. & KRIEG, A.M. (1996). CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12 and interferon ψ. Proceedings of the National Academy of Sciences USA, 93, 2879.
13. KRIEG, A.M., YI, A.-K., MATSON, S., WALDSCHMIDT, T.J., BISHOP, G. A., TEASDALE, R., KORETZKY, G. A. & KLINMAN, DM. (1995). CpG motifs in bacterial DNA trigger direct B-cell activation. Nature, 374, 546.
14. KRIEG, A.M., MATSON, S & FISHER, E. (1996). Oligonucleotide modification determine the magnitude of B-cell stimulation by CpG motifs. Antisense and Nucleic Acid Drug Development, 6, 133.
15. LIANG, H., NISHIOKA, Y., REICH, C.F., PISETSKY, D.S. & LIPSKY, P.E. (1996). Activation of human B cells by phosphorothioate oligodeoxynucleotides. Journal of Clinical Investigation, 98, 1119.
16. MCGRAW, K A., BOGGS, R.T., FLOURNOY, S., CONDON, T.P., BENNETT, C.F & MONIA, B.P. (1996). Characterization of CpG-based immune stimulation by oligonucleotides and it's reduction with modified c-residues. Proceedings of the XII International Roundtable: Nucleosides, Nucleotides and their Biological Applications, La Jolla, CA, September 15.
17. MCINTYRE, K.W., LOMBARD-GILLOOLY, K., PEREZ, J.R , KUNSCH, C., SARMIENTO, U.M., LARIGAN, J.D., LANDRETH, K.T & NARAYANAN, R. (1993). A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor nf-kb p65 causes sequence-specific immune stimulation. Antisense Research and Development, 3, 309.
18. MIRABELLI, C.K., BENNETT, C.F. ANDERSON, K. & CROOKE, S.T. (1991). In vitro and in vivo pharmacologic activities of antisense oligonucleotides. Anti-Cancer Drug Design, 6, 647.
19. PISETSKY, D.S. & REICH, C.F. (1994). Stimulation of murine lymphocyte proliferation by a phosphorothioate oligonucleotide with antisense activity for herpes simplex virus. Life Science, 54, 101.
20. 3H-labeled oligonucleotides. I. Comparison of a phosphodiester and phosphorothioate. Molecular Pharmacology, 45, 932.
21. SARMIENTO, U M., PEREZ, J.R., BECKER. J M. & NARAYANAN, R. (1994). In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice. Antisense Research and Development, 4, 99.
22. SASAKI, T., HORIUCHI, S., YAMAZAKI, M. & YUI, S. (1996). Stimulation of macrophage DNA synthesis by polyanionic substances through binding to the macrophage scavenger receptor. Biology and Pharmacology Bulletin, 19, 449.
23. STEPKOWSKI, S.M., TU, Y, CONDON, T.P. &. BENNETT, C.F. (1994). Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. Journal of Immunology, 153, 5336.
24. YAMAMOTO, T , YAMAMOTO, S , KATAOKA, T & TOKUNAGA, T. (1994). Ability of oligonucleotides with certain palindromes to induce interferon production and augment natural killer cell activity is associated with their base length. Antisense Research and Development, 4, 119.
25. ZHAO, Q . TEMSAMANI, J., IADAROLA, P.L., JIANG, Z & AGRAWAL, S. (1996). Effect of different chemically modified oligodeoxynucleotides on immune stimulation. Biochemical Pharmacology, 51, 173.